C260-1029 Screening compound: methyl 2-{2-[3-(4-{[(2H-1,3-benzodioxol-5-yl)methyl]carbamoyl}butyl)-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-1-yl]acetamido}benzoate

C260-1029 Screening compound: methyl 2-{2-[3-(4-{[(2H-1,3-benzodioxol-5-yl)methyl]carbamoyl}butyl)-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-1-yl]acetamido}benzoate
C260-1029 Screening compound: methyl 2-{2-[3-(4-{[(2H-1,3-benzodioxol-5-yl)methyl]carbamoyl}butyl)-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-1-yl]acetamido}benzoate alternative view

Chemical Structure Depiction of ChemDiv screening compound C260-1029
methyl 2-{2-[3-(4-{[(2H-1,3-benzodioxol-5-yl)methyl]carbamoyl}butyl)-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-1-yl]acetamido}benzoate

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C260-1029

Molecular Formula

C31H30N4O8 (C31 H30 N4 O8)

Compound Name

methyl 2-{2-[3-(4-{[(2H-1,3-benzodioxol-5-yl)methyl]carbamoyl}butyl)-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-1-yl]acetamido}benzoate

IUPAC name

methyl 2-{2-[3-(4-{[(2H-13-benzodioxol-5-yl)methyl]carbamoyl}butyl)-24-dioxo-1234-tetrahydroquinazolin-1-yl]acetamido}benzoate

SMILES

COC(c(cccc1)c1NC(CN(c(cccc1)c1C(N1CCCCC(NCc(cc2)cc3c2OCO3)=O)=O)C1=O)=O)=O

InChI

InChI=1S/C31H30N4O8/c1-41-30(39)21-8-2-4-10-23(21)33-28(37)18-35-24-11-5-3-9-22(24)29(38)34(31(35)40)15-7-6-12-27(36)32-17-20-13-14-25-26(16-20)43-19-42-25/h2-5,8-11,13-14,16H,6-7,12,15,17-19H2,1H3,(H,32,36)(H,33,37)

InChI Key

ORMOVFXAVOMLHT-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14737522

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

586.6

Hydrogen Bond Acceptors Count

13.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

14.00

Number of Nitrogen and Oxygen Atoms

12

Partition Coefficient, logP

2.816

Distribution Coefficient, logD

2.804

Water Solubility, LogSw

-3.44

Polar Surface Area

116.458

Acid Dissociation Constant (pKa)

8.94

Base Dissociation Constant (pKb)

-0.47

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

25.80

C260-1029 in Drug Discovery

Included in Screening Libraries

MCL1 Targeted Library (12200 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic

References: we are preparing a list of scientific research reports with C260-1029 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C260-1029?
Check Price and Availability of C260-1029, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C260-1029 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C260-1029
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C260-1029
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C260-1029 available by request